arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

DNA X, Inc.

SONM

$3.78 ▲ +0.04 (+1.07%) at close

9 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

DNA X, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.7M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC 160.1% ↘

FCF / Share $-32.55 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -0.64

info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$58.30M

↓ -37.7% —

Net Income Profit after all expenses

$-20.66M

↑ +38.6% —

Operating Margin Operating profit as % of sales

-57.7%

↓ -10631.6% —

FCF / Share Free cash flow per share

$-32.55

↓ -1665.4% —

Long-Term Debt Long-term obligations

$5.07M

↑ +7574.2% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

100

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	—	-37.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-855%)	34.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+582%)	28.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+459%)	-14.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-394%)	-45.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-999%)	-14.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-386%)	—	—
EPS Growth YoY (%)	-300.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-35550.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	95.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	88.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	38.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-37286.7% Weak ↓ Weak Declining Year-over-year change in net income	99.4% Excellent ↑ Excellent Improving Year-over-year change in net income	63.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-29.0% Weak Weak Year-over-year change in net income	-15.9% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	-1665.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	-93.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	-122.7% Weak Weak Year-over-year change in free cash flow	89.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	—	2.2% Caution ↑ Caution Improving Compound annual revenue growth over 3 years	13.5% Good ↑ Good Improving Compound annual revenue growth over 3 years	-15.6% Weak Weak Compound annual revenue growth over 3 years	-26.2% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	-12.9% Weak Weak Compound annual revenue growth over 5 years	-7.1% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	—	-57.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-581%)	0.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-95%)	-20.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-271%)	-69.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-680%)	-45.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-481%)	-19.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-260%)	4.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-67%)	—
Effective Tax Rate (%) (%)	14.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	131.7% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	37.1% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	-57.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-821%)	-0.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-101%)	-20.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-352%)	-70.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-985%)	-46.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-685%)	-22.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-378%)	0.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-88%)	—
FCF Margin (%) (%)	—	-14.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-4.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-17.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-70.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-16.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-29.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	2.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.14x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	45.42x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.34x Good Good Free cash flow relative to reported net income Optimal: > 1x	2.41x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	160.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	594.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-0.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-72.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-204.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-100.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	18.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-12.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-84.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-92.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	8.0% Fair Fair Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	259.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1631%)	—	-0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-103%)	-70.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-569%)	-207.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1482%)	-105.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-802%)	-101.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-775%)	24.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+66%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	-0.64x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-191%)	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.40x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-43%)	2.63x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+276%)	—
Interest Coverage (x)	-5.72x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1159.97x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	34.20x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-147.32x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-112.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-21.46x Weak Weak Operating income divided by interest expense Optimal: > 5x	9.88x Good Good Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$3.76M	$-5.34M	$-9.40M	$-13.21M	$-11.17M	$-21.78M	$-1.11M	$461.00K	—
Debt / EBITDA (x)	-0.94x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-0.00x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.54x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.86x Good Good Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	—	$12.36	$21.84	$2.42	$5.77	—	—	—	—
Basic EPS, GAAP (USD)	$-28.58	$-7.13	$-0.02	$-0.49	$-4.08	—	—	—	—
Free Cash Flow per Share (USD)	$-32.55	$-1.84	$-0.95	$-0.43	$-4.07	—	—	—	—
Book Value per Share (USD)	$-6.29	$-1.14	$5.05	$0.49	$0.99	$0.43	$1.25	$0.33	—
Tangible Book Value per Share (USD)	$-6.29	$-1.14	$5.05	$0.49	$0.99	$0.43	$1.25	$0.33	—
Basic Weighted Avg Shares (shares)	722,689	4.72M	4.29M	28.89M	9.46M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$-19.12M	$-11.57M	$11.64M	$11.57M	$14.70M	$25.10M	$19.73M	$15.67M	—
LT Debt (USD)	$5.07M	—	—	—	$66.00K	$362.00K	$10.18M	$13.51M	—
Total Equity (USD)	$-7.96M	$-5.70M	$22.37M	$20.05M	$18.63M	$28.41M	$25.52M	$5.13M	$-89.91M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	—	$58.30M	$93.63M	$69.83M	$54.57M	$63.99M	$116.25M	$135.66M	—
Depreciation Expense (USD)	—	$58.00K	$47.00K	$244.00K	$301.00K	$2.73M	$3.52M	$1.85M	—
Net Income, GAAP (USD)	$-20.66M	$-33.65M	$-90.00K	$-14.09M	$-38.63M	$-29.93M	$-25.83M	$1.28M	—
Operating Cash Flow (USD)	$-23.53M	$-8.49M	$-4.05M	$-12.36M	$-38.48M	$-10.56M	$-33.52M	$3.86M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters

DNA X, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SONM with peers